150 related articles for article (PubMed ID: 11647207)
1. Drug firm, relenting, allows unflattering study to appear.
Altman LK
N Y Times Web; 1997 Apr; ():A1, A16. PubMed ID: 11647207
[No Abstract] [Full Text] [Related]
2. Sponsors lose fight to stop thyroxine study publication.
McCarthy M
Lancet; 1997 Apr; 349(9059):1149. PubMed ID: 11654726
[No Abstract] [Full Text] [Related]
3. Release of study ends drug fracas.
Sternberg S
Sci News; 1997 Apr; 151(16):236. PubMed ID: 11655105
[No Abstract] [Full Text] [Related]
4. Thyroid storm.
Rennie D
JAMA; 1997 Apr; 277(15):1238-43. PubMed ID: 9103350
[No Abstract] [Full Text] [Related]
5. Risky alliance on medicine's cutting edge: firm faces business, ethics issues in NIH joint venture.
Lehrman S
Washington Post; 1991 Aug; ():Business 1, 14. PubMed ID: 11646923
[No Abstract] [Full Text] [Related]
6. Pitching doctors.
Wilkes MS; Shuchman M
N Y Times Mag; 1989 Nov; ():88, 90, 126, 128-129. PubMed ID: 11650264
[No Abstract] [Full Text] [Related]
7. Academics face abuse of rules designed to protect research.
Cowen RC
Christ Sci Monitor; 1998 Mar; ():13. PubMed ID: 11647561
[No Abstract] [Full Text] [Related]
8. Untainted by money.
Loehle C
New Sci; 1997 Aug; 155(2095):44. PubMed ID: 11656796
[No Abstract] [Full Text] [Related]
9. Scientists assail Congress on bill for money to test an AIDS drug.
Meier B
N Y Times Web; 1992 Oct; ():A1, B8. PubMed ID: 11646938
[No Abstract] [Full Text] [Related]
10. Medical journal cites misleading drug research.
Grady D
N Y Times Web; 1999 Nov; ():A18. PubMed ID: 11648133
[No Abstract] [Full Text] [Related]
11. Health chief assails a research deal.
Hilts PJ
N Y Times Web; 1993 Mar; ():A12. PubMed ID: 11646979
[No Abstract] [Full Text] [Related]
12. A cautionary tale.
Zinberg DS
Science; 1996 Jul; 273(5274):411. PubMed ID: 8677431
[No Abstract] [Full Text] [Related]
13. In search of funding: the clinical investigator and the drug company; Commentary: why researchers need not be demoralized.
Siris ES; Burrell CD
IRB; 1983; 5(6):1-5. PubMed ID: 11649526
[No Abstract] [Full Text] [Related]
14. Pushing drugs to doctors.
Consum Rep; 1992 Feb; 57(2):87-94. PubMed ID: 11651202
[No Abstract] [Full Text] [Related]
15. Profits and ethics clash in research on genetic coding.
Fisher LM
N Y Times Web; 1994 Jan; ():1, 18. PubMed ID: 11647947
[No Abstract] [Full Text] [Related]
16. Bioequivalence of levothyroxine preparations: industry sponsorship and academic freedom.
Eckert CH
JAMA; 1997 Apr; 277(15):1200-1. PubMed ID: 9103338
[No Abstract] [Full Text] [Related]
17. New rules will force doctors to disclose ties to drug industry.
Stolberg SG
N Y Times Web; 1998 Feb; ():A12. PubMed ID: 11647602
[No Abstract] [Full Text] [Related]
18. University physician-researcher conflicts of interest: the inadequacy of current controls and proposed reform.
Maatz CT
High Technol Law J; 1992; 7():137-88. PubMed ID: 11659962
[No Abstract] [Full Text] [Related]
19. Ethical oxymora for risk assessment practitioners.
Greenberg MR; Spiro H; McIntyre R
Account Res; 1991; 1(4):245-57. PubMed ID: 11651458
[No Abstract] [Full Text] [Related]
20. Virus.
Bazell R
New Repub; 1992 Nov; 207(20):21-2. PubMed ID: 11659543
[No Abstract] [Full Text] [Related]
[Next] [New Search]
